01—Abstract
Summary
Summary of the 10-Q filed April 30, 2024. Cited figures are marked; the original filing is the authoritative source.
3M Company reported solid financial results for the first quarter of 2024, with net sales of $8.003 billiona, a slight decrease of 0.3% compared to the prior year.
However, operating income saw a significant increase of 20.9% to $1.501 billionb, driven by improved operating margins and effective cost management. Diluted earnings per share (EPS) were $1.67, a decrease from $1.76 in the prior year, primarily impacted by "special items" related to significant litigation and divestiture costs, which the company adjusts for in its non-GAAP reporting to show underlying operational strength. A major development during the quarter was the completion of the spin-off of its Health Care business, now operating as Solventum Corporation, on April 1, 2024.
This strategic move is expected to allow 3M to focus on its core industrial, safety, transportation, electronics, and consumer businesses. The company also continued to manage its significant legal and environmental liabilities, particularly those related to PFAS (per- and polyfluoroalkyl substances) and Combat Arms Earplugs, which continue to impact reported earnings but are being actively addressed through settlements and strategic planning.
02—Key points
Key Highlights
- Net sales for Q1 2024 were $8.003 billion, a slight 0.3% decrease year-over-year.
- Operating income increased by a substantial 20.9% to $1.501 billion, reflecting improved operational efficiency and cost controls.
- Diluted EPS was $1.67, down from $1.76 in Q1 2023, largely due to "special items" including litigation and divestiture costs.
- The company completed the spin-off of its Health Care business (Solventum) on April 1, 2024, to sharpen its strategic focus.
- The Safety and Industrial segment showed resilience with a 9.3% increase in operating income, while Transportation and Electronics saw a significant 63.5% surge in operating income.
- Free cash flow for the quarter was $392 million, a decrease from $800 million in the prior year, impacted by higher litigation payments.
- 3M continues to address significant legal liabilities, particularly related to PFAS and Combat Arms Earplugs, with ongoing settlement activities and provisions.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2024, 3M Co kept $0.15.
- Revenue$6.02B100.0%
- Cost of revenue−$3.48B57.9%
- Gross profit$2.53B42.1%
- Operating costs−$1.38B23.0%
- Operating income$1.15B19.1%
- Interest, other & tax−$221.0M3.7%
- Net income$928.0M15.4%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2024filed April 30, 2024Financial Statements
Q1 FY2024 against Q1 FY2023
| Line item | Q1 FY2024Q1 FY2023 | Change |
|---|---|---|
| Revenue | $6.02B$6.05B | −0.6% |
| Cost of Revenue | $3.48B$3.74B | −6.9% |
| Gross Profit | $2.53B$2.31B | +9.5% |
| SG&A Expenses | $1.13B$1.71B | −33.8% |
| Operating Expenses | $4.87B$6.79B | −28.3% |
| Operating Income | $1.15B$1.24B | −7.4% |
| Interest Expense | $137.00M$123.00M | +11.4% |
| Net Income | $928.00M$976.00M | −4.9% |
| EPS (Basic) | $1.67$1.77 | −5.6% |
| EPS (Diluted) | $1.67$1.76 | −5.1% |
| Shares Outstanding (Basic) | 555.00M552.70M | +0.4% |
| Shares Outstanding (Diluted) | 555.90M553.20M | +0.5% |
05—Questions
Frequently Asked Questions
What was 3M's financial performance in Q1 2024?
In the first quarter of 2024, 3M reported net sales of $8.003 billion, a slight decrease of 0.3% year-over-year. However, operating income saw a significant increase of 20.9% to $1.501 billion, demonstrating improved operational leverage and cost management. Diluted earnings per share were $1.67, down from $1.76 in the prior year, mainly due to "special items" related to litigation and divestiture costs.
What are the key strategic developments from this quarter?
The most significant strategic event was the completion of the spin-off of 3M's Health Care business into a new, independent public company called Solventum Corporation, effective April 1, 2024. This move aims to allow 3M to concentrate on its core industrial, safety, transportation, electronics, and consumer segments.
How are the "special items" impacting 3M's results?
3M's reported earnings are significantly affected by "special items," which include costs associated with major litigation (such as PFAS and Combat Arms Earplugs) and divestiture costs related to the Solventum spin-off. While these items reduce reported EPS, the company provides "adjusted" or non-GAAP figures to offer insight into the ongoing operational performance.
What is the outlook for the company's major business segments?
The Safety and Industrial segment experienced a modest sales decline but showed strong operating income growth. The Transportation and Electronics segment saw solid sales and a substantial increase in operating income, driven by automotive electrification and consumer electronics. The Health Care segment (prior to spin-off) and Consumer segment experienced slight sales declines, with Health Care operating income impacted by stand-up costs and Consumer segment by softer consumer discretionary spending.
06—Continue